Krystal Biotech (KRYS) Short Interest Ratio & Short Volume $186.88 +4.26 (+2.33%) As of 11:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Krystal Biotech Short Interest DataKrystal Biotech (KRYS) has a short interest of 3.01 million shares. This marks a -7.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.5, indicating that it would take 11.5 days of the average trading volume of 253,511 shares to cover all short positions.Current Short Interest3,010,000 sharesPrevious Short Interest3,250,000 sharesChange Vs. Previous Month-7.38%Dollar Volume Sold Short$480.82 millionShort Interest Ratio11.5 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares28,760,000 sharesPercentage of Shares Shorted10.47%Today's Trading Volume50,182 sharesAverage Trading Volume253,511 sharesToday's Volume Vs. Average20% Short Selling Krystal Biotech? Sign up to receive the latest short interest report for Krystal Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRYS Short Interest Over TimeKRYS Days to Cover Over TimeKRYS Percentage of Float Shorted Over Time Krystal Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20253,010,000 shares $480.82 million -7.4%N/A11.5 $159.74 1/15/20253,250,000 shares $475.93 million -3.6%N/A12.2 $146.44 12/31/20243,370,000 shares $527.94 million -8.9%N/A13.6 $156.66 12/15/20243,700,000 shares $605.47 million +1.4%N/A15.4 $163.64 11/30/20243,650,000 shares $720.58 million +1.4%N/A15.5 $197.42 11/15/20243,600,000 shares $614.66 million +4.4%N/A15.7 $170.74 10/31/20243,450,000 shares $595.23 million -2.5%N/A16.1 $172.53 10/15/20243,540,000 shares $631.75 million +0.6%N/A15.6 $178.46 9/30/20243,520,000 shares $640.75 million -4.1%N/A13.9 $182.03 9/15/20243,670,000 shares $739.80 million -0.5%N/A12.9 $201.58 Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/31/20243,690,000 shares $719.99 million +4.2%N/A9.5 $195.12 8/15/20243,540,000 shares $686.69 million +1.1%N/A9.1 $193.98 7/31/20243,500,000 shares $729.61 million -4.6%N/A8.8 $208.46 7/15/20243,670,000 shares $762.92 million +4.6%N/A9.4 $207.88 6/30/20243,510,000 shares $644.58 million +21.0%N/A9.1 $183.64 6/15/20242,900,000 shares $515.56 million +7.8%N/A7.7 $177.78 5/31/20242,690,000 shares $430.53 million -4.3%N/A8.6 $160.05 5/15/20242,810,000 shares $458.56 million +8.5%N/A7.5 $163.19 4/30/20242,590,000 shares $396.58 million +5.7%N/A6.6 $153.12 4/15/20242,450,000 shares $415.89 million +12.9%N/A6.2 $169.75 3/31/20242,170,000 shares $386.11 million -3.1%N/A5.5 $177.93 3/15/20242,240,000 shares $387.48 million -10.8%N/A5.8 $172.98 2/29/20242,510,000 shares $400.27 million +1.6%N/A6.5 $159.47 2/15/20242,470,000 shares $280.05 million +21.7%N/A7.3 $113.38 1/31/20242,030,000 shares $225.84 million +3.1%N/A6.6 $111.25 1/15/20241,970,000 shares $252.87 million -9.2%N/A6.3 $128.36 12/31/20232,170,000 shares $269.21 million +11.3%N/A7.1 $124.06 12/15/20231,950,000 shares $225.73 million -8.0%N/A6.4 $115.76 11/30/20232,120,000 shares $220.97 million +2.4%N/A6.8 $104.23 11/15/20232,070,000 shares $206.09 million -1.4%N/A6.8 $99.56 10/31/20232,100,000 shares $245.43 million +7.1%N/A7.1 $116.87 10/15/20231,960,000 shares $223.01 million -0.5%N/A7.4 $113.78 9/30/20231,970,000 shares $228.52 million +23.9%N/A7.4 $116.00 9/15/20231,590,000 shares $191.07 million +6.0%N/A5.9 $120.17 8/31/20231,500,000 shares $186.72 million -2.6%N/A5.7 $124.48 8/15/20231,540,000 shares $187.82 million +15.8%N/A5.3 $121.96 7/31/20231,330,000 shares $171.70 million -7.6%N/A4.1 $129.10 7/15/20231,440,000 shares $181.83 million +6.7%6.8%4.7 $126.27 6/30/20231,350,000 shares $158.49 million +3.1%6.4%4.5 $117.40 6/15/20231,310,000 shares $163.37 million +10.1%6.2%4.3 $124.71This simple indicator removes the “technical” out of technical trading (Ad)Experts are calling it the best buy/sell indicator of 2024… A finance whiz from northern Florida has coded an indicator that isolates the precise dates to buy in and out of the stock market. According to the creator, it allows him to ride all the market highs yet sidestep the lows. And for the first time ever, he’s sharing his indicator with the public. As you’ll see in today’s free trading session, you simply buy when the candles turn green and sell when they turn red. It only takes about 2 minutes, and it’s made a huge impact on how hundreds of people buy and sell st 5/31/20231,190,000 shares $140.24 million +3.5%5.6%4.3 $117.85 5/15/20231,150,000 shares $103.56 million -0.9%5.5%4.4 $90.05 4/30/20231,160,000 shares $97.44 million -7.2%5.5%5.7 $84.00 4/15/20231,250,000 shares $107.98 million +4.2%6.0%6.4 $86.38 3/31/20231,200,000 shares $96.07 million +5.3%5.8%5.9 $80.06 3/15/20231,140,000 shares $83.80 million -4.2%5.5%5.9 $73.51 2/28/20231,190,000 shares $97.47 million +6.3%5.7%6.3 $81.91 2/15/20231,120,000 shares $82.33 million +6.7%5.4%6.5 $73.51 1/31/20231,050,000 shares $87.28 million -7.1%5.1%6.1 $83.12 1/15/20231,130,000 shares $93.73 million +14.4%5.4%6.5 $82.95 12/30/2022988,100 shares $78.28 million -10.2%4.8%5.9 $79.22 12/15/20221,100,000 shares $86.24 million -9.1%5.3%6.9 $78.40 11/30/20221,210,000 shares $94.07 million -3.2%5.9%7.8 $77.74 11/15/20221,250,000 shares $96.51 million -4.6%6.1%7.7 $77.21 10/31/20221,310,000 shares $100.22 million +3.2%6.4%7.9 $76.50 10/15/20221,270,000 shares $83.83 million -3.1%6.2%7.6 $66.01 9/30/20221,310,000 shares $91.31 million +7.4%6.4%7.9 $69.70 9/15/20221,220,000 shares $86.97 million -4.7%6.3%7.3 $71.29 8/31/20221,280,000 shares $89.74 million -5.9%6.6%7.2 $70.11 8/15/20221,360,000 shares $105.48 million -0.7%7.0%7.9 $77.56 7/31/20221,370,000 shares $99.43 million -1.4%7.0%7.5 $72.58 7/15/20221,390,000 shares $100.66 million -10.9%7.1%7.7 $72.42 6/30/20221,560,000 shares $102.43 million -2.5%7.9%8.6 $65.66 6/15/20221,600,000 shares $85.34 million +0.6%8.1%8.4 $53.34 5/31/20221,590,000 shares $93.62 million -1.2%8.1%7.8 $58.88 5/15/20221,610,000 shares $90.77 million +2.6%8.2%7.6 $56.38 4/30/20221,570,000 shares $95.16 million -7.1%8.1%7.4 $60.61 4/15/20221,690,000 shares $122.51 million +5.0%8.7%8 $72.49 3/31/20221,610,000 shares $107.13 million +17.5%8.4%7.2 $66.54 3/15/20221,370,000 shares $84.98 million +13.2%7.1%6.3 $62.03 2/28/20221,210,000 shares $76.90 million +4.3%6.4%5.2 $63.55 2/15/20221,160,000 shares $78.11 million +9.4%N/A2.6 $67.34 1/31/20221,060,000 shares $62.54 million -1.9%5.6%2.4 $59.00 1/15/20221,080,000 shares $67.26 million +4.9%5.7%2.4 $62.28 12/31/20211,030,000 shares $72.05 million -25.4%5.4%2.4 $69.95 12/15/20211,380,000 shares $99.98 million -37.6%7.3%3.3 $72.45 11/30/20212,210,000 shares $178.02 million +6.8%12.3%5.7 $80.55 11/15/20212,070,000 shares $98.22 million +12.5%12.9%13.6 $47.45 10/29/20211,840,000 shares $92.17 million +5.8%11.5%14.2 $50.09 10/15/20211,740,000 shares $84.77 million +13.0%10.8%15 $48.72 9/30/20211,540,000 shares $80.40 million -0.7%9.6%13.6 $52.21 9/15/20211,550,000 shares $86.89 million -4.3%9.7%12.5 $56.06 8/31/20211,620,000 shares $93.86 million +12.5%10.1%12.6 $57.94 8/13/20211,440,000 shares $80.90 million +7.5%9.0%11.6 $56.18 7/30/20211,340,000 shares $78.31 million +24.1%8.4%10.9 $58.44 7/15/20211,080,000 shares $67.46 million -1.8%6.8%9.3 $62.46 6/30/20211,100,000 shares $74.80 million -4.4%6.9%10.1 $68.00 6/15/20211,150,000 shares $72.91 million -0.9%7.2%11.8 $63.40 5/28/20211,160,000 shares $75.68 million -4.1%7.3%11.5 $65.24 5/14/20211,210,000 shares $75.67 million -2.4%7.6%10.7 $62.54This simple indicator removes the “technical” out of technical trading (Ad)Experts are calling it the best buy/sell indicator of 2024… A finance whiz from northern Florida has coded an indicator that isolates the precise dates to buy in and out of the stock market. According to the creator, it allows him to ride all the market highs yet sidestep the lows. And for the first time ever, he’s sharing his indicator with the public. As you’ll see in today’s free trading session, you simply buy when the candles turn green and sell when they turn red. It only takes about 2 minutes, and it’s made a huge impact on how hundreds of people buy and sell st 4/30/20211,240,000 shares $99.35 million +3.3%7.8%9.2 $80.12 4/15/20211,200,000 shares $89.72 million -3.2%7.5%8 $74.77 3/31/20211,240,000 shares $90.43 million +6.9%7.9%8 $72.93 3/15/20211,160,000 shares $96.06 million -2.5%7.4%7.1 $82.81 2/26/20211,190,000 shares $93.87 million +10.2%7.9%7.3 $78.88 2/12/20211,080,000 shares $74.19 million -10.7%7.2%6.5 $68.69 1/29/20211,210,000 shares $85.51 million -6.2%8.1%7.3 $70.67 1/15/20211,290,000 shares $85.58 million -5.8%9.6%8.6 $66.34 12/31/20201,370,000 shares $82.76 million +2.2%10.2%9.3 $60.41 12/15/20201,340,000 shares $78.26 million -2.2%10.0%9 $58.40 11/30/20201,370,000 shares $66.94 million -4.2%10.2%9.8 $48.86 11/15/20201,430,000 shares $59.89 million -7.1%10.7%10.6 $41.88 10/30/20201,540,000 shares $69.79 million -11.0%11.5%12.1 $45.32 10/15/20201,730,000 shares $86.60 million -3.9%13.0%13.6 $50.06 9/30/20201,800,000 shares $77.49 million +8.4%13.5%14.1 $43.05 9/15/20201,660,000 shares $76.71 million +1.8%12.4%11.7 $46.21 8/31/20201,630,000 shares $77.93 million +4.5%12.3%10.8 $47.81 8/14/20201,560,000 shares $66.46 million -3.7%11.7%9.6 $42.60 7/31/20201,620,000 shares $66.89 million +2.5%12.2%8.5 $41.29 7/15/20201,580,000 shares $63.37 million No Change11.9%8.5 $40.11 6/30/20201,580,000 shares $65.25 million +29.5%12.7%7.9 $41.30 6/15/20201,220,000 shares $55.47 million +3.4%9.8%6.3 $45.47 5/29/20201,180,000 shares $59.44 million -8.5%10.8%6.1 $50.37 5/15/20201,290,000 shares $76.37 million -9.2%11.8%6.7 $59.20 4/30/20201,420,000 shares $67.01 million -6.0%13.0%9.1 $47.19 4/15/20201,510,000 shares $68.18 million +3.4%13.8%9.5 $45.15 3/31/20201,460,000 shares $71.35 million -11.2%13.3%9.1 $48.87 3/13/20201,644,500 shares $72.72 million +11.1%20.8%11.2 $44.22 2/28/20201,480,000 shares $53.31 million -0.7%18.7%9.8 $36.02 KRYS Short Interest - Frequently Asked Questions What is Krystal Biotech's current short interest? Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 3,010,000 shares of KRYS short. Learn More on Krystal Biotech's current short interest. What is a good short interest ratio for Krystal Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRYS shares currently have a short interest ratio of 12.0. Learn More on Krystal Biotech's short interest ratio. Which institutional investors are shorting Krystal Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Krystal Biotech: Wolverine Trading LLC, Millennium Management LLC, LMR Partners LLP, Caption Management LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Jane Street Group LLC, Nantahala Capital Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Krystal Biotech's short interest increasing or decreasing? Krystal Biotech saw a decline in short interest in January. As of January 31st, there was short interest totaling 3,010,000 shares, a decline of 7.4% from the previous total of 3,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Krystal Biotech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Krystal Biotech: Summit Therapeutics Inc. (2.83%), Genmab A/S (0.26%), Intra-Cellular Therapies, Inc. (1.50%), Viatris Inc. (2.60%), Moderna, Inc. (11.84%), Dr. Reddy's Laboratories Limited (1.90%), Vaxcyte, Inc. (10.86%), Sarepta Therapeutics, Inc. (5.29%), Qiagen (1.18%), Ascendis Pharma A/S (5.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Krystal Biotech stock? Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. KRYS shares are trading up $4.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Krystal Biotech? A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further. How often is Krystal Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies SMMT Short Interest Data GMAB Short Interest Data ITCI Short Interest Data VTRS Short Interest Data MRNA Short Interest Data RDY Short Interest Data PCVX Short Interest Data SRPT Short Interest Data QGEN Short Interest Data ASND Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRYS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
